EZETIMIBE TARO 10 MG

البلد: إسرائيل

اللغة: الإنجليزية

المصدر: Ministry of Health

العنصر النشط:

EZETIMIBE

متاح من:

TARO INTERNATIONAL LTD, ISRAEL

ATC رمز:

C10AX09

الشكل الصيدلاني:

TABLETS

تركيب:

EZETIMIBE 10 MG

طريقة التعاطي:

PER OS

نوع الوصفة الطبية :

Required

المصنعة من قبل:

OHM LABORATORIES, INC., USA

المجال العلاجي:

EZETIMIBE

الخصائص العلاجية:

Primary hypercholesterolemia: Ezetimibe Taro administered with an HMG-CoA reductase inhibitor (statin) or alone are indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial and non-familial) hypercholesterolemia. Homozygous familial hypercholesterolemia (HoFH): Ezetimibe Taro administered with a statin are indicated for use in patients with HoFH. Patients may also receive adjunctive treatments (e.g. LDL apheresis). Homozygous sitosterolemia (Phytosterolemia): Ezetimibe Taro are indicated for use in patients with homozygous familial sitosterolemia.

تاريخ الترخيص:

2023-03-21

نشرة المعلومات

Patient leaflet in accordance with the Pharmacists' Regulations
(Preparations) – 1986
This medicine is dispensed with a doctor’s prescription only
Ezetimibe Taro 10 mg
Tablets
Active ingredient
Each tablet contains 10 mg ezetimibe
Inactive ingredients and allergens in this medicine: see section 2
under ‘Important
information about some of this medicine’s ingredients’, and
section 6 ‘Additional
information’.
Read the entire leaflet carefully before you start using this
medicine.
This leaflet
contains concise information about this medicine. If you have any
further questions, consult
your doctor or pharmacist.
This medicine has been prescribed for you. Do not pass it on to
others. It may harm them,
even if it seems to you that their medical condition is similar to
yours.
1.
What is this medicine intended for?
Ezetimibe Taro 10 mg is intended for patients with:
−
primary heterozygous familial and non-familial hypercholesterolemia
(conditions in
which there is a high cholesterol level in the blood), as a single
treatment or in
combination with a statin (HMG-CoA reductase inhibitor) as adjunctive
to diet.
−
homozygous familial hypercholesterolemia (a condition in which there
is a high
cholesterol level in the blood), in combination with a statin and
other treatments for
reduction of lipid levels in the blood (e.g. LDL apheresis).
−
homozygous familial sitosterolemia (disorder of lipid absorption and
removal from the
gastrointestinal tract).
Therapeutic group:
Ezetimibe is a member of a class of medicines called CAI (cholesterol
absorption inhibitors),
which inhibit intestinal absorption of cholesterol.
Ezetimibe Taro 10 mg
is used to lower high blood levels of lipids.
Ezetimibe Taro 10 mg
is sometimes given together with medicines from the statin class
(e.g., simvastatin, atorvastatin, etc.). If that is the case, read the
statin’s patient information
leaflet carefully before starting treatment, and consult your doctor.
2.
Before using this medicine
Do not use this medicine:
-
if you are sensitive